Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649385 Isolated nucleic acid molecules encoding human squalene synthase proteins, and related products and processes
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003US6649359 Diagnosis of endometrial precancers
11/18/2003US6649353 Method for influencing the p53 linkage to target genes
11/18/2003US6649352 Method of evaluating myelosuppressive state
11/18/2003US6649340 Protein which contains a predetermined amino acid in the hypervariable region of the antigen-binding site; use in studying structure/ function and in developing new enzymes and antibodies
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/18/2003US6649163 Treatment and diagnosis of cancer
11/18/2003CA2265508C Bone morphogenetic protein-16 (bmp-16) compositions
11/17/2003CA2429483A1 Immunointeractive molecules
11/13/2003WO2003093825A1 Method for diagnosing neoplasms
11/13/2003WO2003093493A2 Pregnancy detection
11/13/2003WO2003093474A1 Psp94 binding protein and psp94 diagnostic assays
11/13/2003WO2003093447A2 Microglial inactivation
11/13/2003WO2003093446A2 Antibodies for enhancing neurite outgrowth
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093415A2 Methods useful in treatment and prevention of hiv infection
11/13/2003WO2003093320A2 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses
11/13/2003WO2003093319A1 Novel humanized anti-vap-1 monoclonal antibody
11/13/2003WO2003093318A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003WO2003093317A1 Antibody to human insulin-like growth factor
11/13/2003WO2003093315A2 Specific antibody fragments for the human carcinoembryonic antigen (cea)
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093311A1 Proteins with deglycating activities and methods of using same
11/13/2003WO2003092717A1 Cancer immunotherapy
11/13/2003WO2003092714A2 Peptide variants of ige constrained by beta-lactam bond
11/13/2003WO2003092630A2 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003092615A2 Use of anti-cd1 antibodies for the modulation of immune responses
11/13/2003WO2003092611A2 Methods of inducing formation of functional and organized lymphatic vessels
11/13/2003WO2003092610A2 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092597A2 Antibodies that specifically bind to chemokine beta-4
11/13/2003WO2003076465A3 Downregulation of ca 125 tumor antigen and uses thereof
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
11/13/2003WO2003035695A3 Agents that activate or inhibit toll-like receptor 9
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003015902A3 High strength asymmetric cellulosic membrane
11/13/2003WO2003000889A3 Identification of ses-1 and the uses of the same
11/13/2003WO2003000117A3 Detection and treatment of prostate cancer
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002090549A3 Compositions and methods for the modulation of viral maturation
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
11/13/2003WO2002076406A3 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
11/13/2003WO2002072888A3 Polymorphisms in the human cmoat gene and uses thereof
11/13/2003WO2002066648A3 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
11/13/2003WO2002065126A8 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002057290A8 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents
11/13/2003US20030212027 Vaccine formulations and methods for immunizing an individual against shed antigen specific B cells
11/13/2003US20030212023 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211977 Muscle relaxants; anticoagulants; cardiovascular disorders
11/13/2003US20030211967 Method for selectively inhibiting ghrelin action
11/13/2003US20030211636 Determining dosage of drugs metabolized by cytochrome P450 such as 2-methoxy-5-trifluoromethoxy-benzyl)-(2-phenyl-piperidin-3-yl)-amine; antibodies
11/13/2003US20030211587 Keptin-a novel keratinocyte-specific proteinase inhibitor
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211571 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes by contacting blood with polypeptide; cancer diagnosis
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211569 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211553 Selectively-expressed epitope on the human CD38 molecule detected by a phage display library-derived human scFv antibody fragment
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211533 Method for testing a therapeutic or preventive agent for hyperlipidemia
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211519 Identifying angiogenesis inhibitor for treating cell proliferative disorders; antitumor agents
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211470 Comprises chimeric heterotetrameric heavy chain polypeptides (CD4-IgG2) for use in the prevention and treatment of viral diseases; immunoassay
11/13/2003US20030211468 Comprises monoclonal antibody which deactivates kaposi's sarcoma associated herpesvirus interleukin-6 (KSRV VIL-6) for treating, diagnosing and prognosing oncogenic viral infections; antiarthritic agents; antitumor agents
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211463 Monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy
11/13/2003US20030211112 EGFR ligands and methods of use
11/13/2003US20030211111 Antibodies to biological membranes
11/13/2003US20030211110 Administering immunoglobulins; determination titration of antibodies
11/13/2003US20030211108 Monoclonal antibody inducing apoptosis
11/13/2003US20030211107 Use of CD23 antagonists for the treatment of neoplastic disorders
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211105 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity
11/13/2003US20030211104 Methods of using cytokine antagonists to treat HIV infection and AIDS
11/13/2003US20030211103 Use of primate IFN-gamma binding molecules
1 ... 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 ... 1494